2023

Citing “policy and operational challenges” with the current 340B Administrative Dispute Resolution (ADR) Process, the US…

On December 14, 2022, the Biden administration released a proposal to streamline Medicare Advantage (MA) and Part D plan prior…

CMS has issued a new rule meant to streamline prior authorization by requiring certain payers to implement an electronic prior…

The Department of Justice has announced inflationary adjustments to the False Claims Act’s civil monetary penalties as a result of…

The United States Department of Health and Human Services (HHS) Office for Civil Rights (OCR) issued a bulletin to clarify…

The 20th Pharmaceutical Compliance Congress (PCC) is scheduled to be delivered as a hybrid event from April 25, 2023, through…

The Open Payments data is now updated to reflect changes to the data that took place since the June 2022 publication and is…

In 2022, the United States Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) approved 37 new drugs…

The Department of Health and Human Services Office of Inspector General (HHS OIG) published a report that found while the Centers…

AMGA recently sent a letter to the Congressional Telehealth Caucus, agreeing that updates should be made to the CONNECT Act to…